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Background: Ginsenoside Rd (GSRd), one of the most abundant ingredients of Panax ginseng, protects the
heart via multiple mechanisms including the inhibition of Ca2þ inﬂux. We intended to explore the effects
of GSRd on L-type Ca2þ current (ICa,L) and deﬁne the mechanism of the suppression of ICa,L by GSRd.
Methods: Perforated-patch recording and whole-cell voltage clamp techniques were applied in isolated
rat ventricular myocytes.
Results: (1) GSRd reduced ICa,L peak amplitude in a concentration-dependent manner [half-maximal
inhibitory concentration (IC50) ¼ 32.4  7.1 mmol/L] and up-shifted the currentevoltage (IeV) curve. (2)
GSRd (30 mmol/L) signiﬁcantly changed the steady-state activation curve of ICa,L (V0.5: 19.12  0.68 vs.
16.26  0.38 mV; n ¼ 5, p < 0.05) and slowed down the recovery of ICa,L from inactivation [the time
content (z) from 91 ms to 136 ms, n ¼ 5, p < 0.01]. (3) A more signiﬁcant inhibitive effect of GSRd
(100 mmol/L) was identiﬁed in perforated-patch recording when compared with whole-cell recording
[65.7  3.2% (n ¼ 10) vs. 31.4  5.2% (n ¼ 5), p < 0.01]. (4) Pertussis toxin (Gi protein inhibitor) completely
abolished the ICa,L inhibition induced by GSRd. There was a signiﬁcant difference in inhibition potency
between the two cyclic adenosine monophosphate elevating agents (isoprenaline and forskolin) pres-
timulation [55  7.8% (n ¼ 5) vs. 17.2  3.5% (n ¼ 5), p < 0.01]. (5) 1H-[1,2,4]Oxadiazolo[4,3-a]-qui-
noxalin-1-one (a guanylate cyclase inhibitor) and N-acetyl-L-cysteine (a nitric oxide scavenger) partly
recovered the ICa,L inhibition induced by GSRd. (6) Phorbol-12-myristate-13-acetate (a protein kinase C
activator) and GF109203X (a protein kinase C inhibitor) did not contribute to the inhibition of GSRd.
Conclusion: These ﬁndings suggest that GSRd could inhibit ICa,L through pertussis toxin-sensitive G
protein (Gi) and a nitric oxideecyclic guanosine monophosphate-dependent mechanism.
Copyright  2014, The Korean Society of Ginseng, Published by Elsevier. All rights reserved.1. Introduction
Panax ginseng, a traditional herbal medicine, has been used to
prevent or treat cardiovascular diseases for at least 2000 years. Gin-
senosides, a special group of triterpenoid saponins, are found nearly
exclusively in ginseng and have been reported to show potential
cardiovascular beneﬁts through diverse mechanisms: antioxidation,
modifying vasomotor function, reducing platelet adhesion, inﬂu-
encing ion channels, altering autonomic neurotransmitters release,
and improving lipid proﬁles [1e3]. Among the various ginsenosides,
such as Rb, Rc, Rd, Re, Rf, and Rg, ginsenoside Rd (GSRd) is one of the
most abundant ingredients in the ginseng root and consequently hasryngology, Beijing Friendship Hosp
).
erms of the Creative Commons At
ribution, and reproduction in any
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GSRd can be produced through the hydrolysis of sugarmoieties from
the major ginsenosides, making it inexpensive for pharmaceutical
use [4]. GSRd has exhibited an encouraging neuroprotective effect in
both laboratory and clinical studies [5]. Recently, it has become
important to show that GSRd attenuates myocardial ischemia/
reperfusion injury in a rat model and in cultured neonatal rat car-
diomyocyte model, which is related to the beneﬁcial effects of
ginseng in the treatment of heart diseases directly [6]. Multiple
mechanisms were elucidated to be involved in the cardioprotective
effects of GSRd, which should act synergically in ischemic myocar-
dium. Therefore, in addition to being highly lipophilic and the factital Afﬁliated to Capital Medical University, No. 95 Yongan Road, Xicheng District,
tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)
medium, provided the original work is properly cited.
ished by Elsevier. All rights reserved.
J Ginseng Res 2015;39:169e177170that it is capable of easy diffusion across biologicalmembranes, GSRd
may have a potential clinical beneﬁt on heart diseases.
In the mechanism research, GSRd-mediated cardioprotective
effects against myocardial ischemia/reperfusion were found by
both reducing intracellular reactive oxygen species and inhibiting
mitochondria-mediated apoptosis. The activation of Akt/GSK-3b
signaling is involved in the cardioprotective effect of GSRd [6].
Moreover, some data have shown that GSRd blocked Ca2þ inﬂux
through receptor- and store-operated Ca2þ channels in vascular
smooth muscle cells [7]. Because Ca2þ antagonists effectively pro-
tect the myocardium from ischemic injury, we speculated that
GSRd might exert its protective effects via blocking of Ca2þ channel
in cardiomyocytes. In this study, we focused on the effects of GSRd
on L-type calcium channel current (Ca2þ, the antagonists’ target) in
isolated rat ventricular myocytes and its potential mechanism.
2. Materials and methods
2.1. Care and use of experimental animals
The experiment was performed in accordance with the insti-
tutional guidelines on the care and use of experimental animals set
by the Chinese Academy of Sciences.
2.2. Cell preparation and solutions
The ventricular myocytes were enzymatically isolated from the
hearts of male SpragueeDawley rats (Vital River Laboratory Animal
Technology Co. Ltd., Beijing, China) and stored in KrafteBruthe (KB)
medium as previously described [8]. Brieﬂy, the hearts were quickly
removed and retrogradely perfused through the aorta with a0
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Fig. 1. Effect of ginsenoside Rd (GSRd) on peak ICa,L in adult rat ventricular myocytes. Myo
voltage pulse to 0 mV. (A) Consecutive exposure to different concentration GSRd (10 mmol/
Upon washout of GSRd, ICa,L partially recovered. (B) Initial superimposed current traces of c
Data ﬁtted cell by cell to the following equation: IR ¼ IRmax/[1 þ ([C]/IC50)b], where IR is the i
maximum inhibition; b ¼ Hill index. IC50 of GSRd was 32.4  7.1 mmol/L, with a Hill coefﬁCa2+-free Tyrode’s solution for 5min at 37C, followed by a low Ca2+
concentration Tyrode’s solution containing type II collagenase
(0.4 mg/mL) (Worthington, USA), Protease XIV (0.03 mg/mL),
and bovine serum albumin (1 mg/mL) for 18e25 min. Tyrode’s
solution contained NaCl (135 mmol/L), KCl (5.4 mmol/L),
MgCl2 (1 mmol/L), NaH2PO4 (0.33 mmol/L), 4-(2-Hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) (10 mmol/L), and glucose
(10 mmol/L) (pH 7.4 NaOH), and was oxygenated with 100%
oxygen. The ventricles were then minced and gently triturated in
Kraft-Bruthe (KB) medium containing KOH (70 mmol/L), KCl
(40 mmol/L), KH2PO4 (20 mmol/L), glutamic acid (50 mmol/L),
MgCl2 (3 mmol/L), taurine (20 mmol/L), EGTA (0.5 mmol/L), HEPES
(10mmol/L), and glucose (10mmol/L) (pH 7.4 KOH). Myocyteswere
harvested using a 200-mm nylon mesh and stored in KB medium
at 4C.
2.3. Perforated and whole-cell patch clamp recording
A small aliquot of ventricular myocytes were placed into a 2-mL
chambermounted on the stage of amicroscope (DMIRB, LAICA, GER)
and superfused with an external solution via a pump (BT100-2J,
LONGER, CHN) at a rate of 3 mL/min. GSRd and some drug solutions
were directly applied to the myocyte body using a pressurized bath
perfusion system (BPS-8, ALA, USA). Patch pipetteswere pulled using
a puller (PULL100, WPI, USA) and had a tip resistance of 2e4 MU
when ﬁlledwith a pipette solution. Perforated patch clamp recording
used an amphotericin B-perforated patch, which minimized the
dialysis of intracellular contentswith the internal pipette solution [9].
Amphotericin B was dissolved in dimethyl sulfoxide at a concentra-
tion of 60mg/mL, and then added to the internal pipette solution at a
ﬁnal amphotericin B concentration of 0.2e0.3 mg/mL. The pipette100 1000
l/L)
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c
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cytes were voltage-clamped at 40 mV, and ICa,L was repetitively elicited by a single
L, 30 mmol/L, and 100 mmol/L) resulted in consecutive further suppression of peak ICa,L.
ontrol and GSRd at times (aed) indicated in A. (C) The concentrationeresponse curve.
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Fig. 2. Effect of ginsenoside Rd (GSRd) on currentevoltage relationship curves. (A) Initial currentevoltage superimposed traces of control and GSRd (10 mmol/L and 30 mmol/L);
250 ms steps from 40 mV to between 40 mV and þ70 mV at 1 Hz. (B) Currentevoltage relationship curves prior to and after GSRd (10 mmol/L and 30 mmol/L).
Fig. 3. Effect of ginsenoside Rd (GSRd) on steady-state activation and inactivation. For
the activation curves, the voltage dependence of the conductance activation variable
were ﬁtted to Boltzmann distribution: G/Gmax ¼ 1/{1 þ exp[(V  V0.5)/k]}, where G/
Gmax is the ratio of conductances [G ¼ I/(V  Vrev), where Vrev is the reversal potential
from each IeV curve)] to maximum conductance (Gmax, measured at 0 mV); V is the
membrane potential, V0.5 is the midpoint, and k is the slope. V0.5 and k
were 19.12  0.68 mV and 4.26  0.78 mV in the control, and 16.26  0.38 mV and
4.61  0.32 mV in GSRd (30 mmol/L). For the inactivation curves, protocol and repre-
sentative recordings used to assess availability (I/Imax) are shown at lower left. I/Imax
were also ﬁtted to Boltzmann distribution. Currents (I) at 0 mV after 1-s conditioning
pulses between 50 mV and 20 mV to 0 mV with 250 ms square wave were
normalized by maximum current (Imax). V0.5 and k were 28.34  0.45 mV and
4.41  0.42 mV in the control, and 28.99  0.28 mV and 4.21  0.28 mV after GSRd
application.
C. Lu et al / Effect of ginsenoside Rd on L-type Ca2+ channel 171solution containing amphotericin B was sonicated prior to use. The
internal pipette solution contained CsCl (140 mmol/L), MgCl2
(2mmol/L), CaCl2 (1mmol/L), EGTA (11mmol/L), MgATP (5mmol/L),
and HEPES (10mmol/L) (pH 7.2 CsOH). Tyrode’s solutionwas used to
record ICa, L. Immediately after gigaseal formation (seal resistance
>1 GU), the access resistance was monitored for 3e5 min. The in-
ternal pipette solution and the external solution for whole-cell patch
recording were in accordance with perforated patch recording. The
membrane was ruptured with a gentle suction after gigaseal for-
mation to obtain the whole-cell patch clamp conﬁguration. Voltage
clamp recording was performed in single ventricular myocyte using
an ampliﬁer (EPC-10, HEKA, GER). Voltage command protocols were
provided by a software package (PULSE10.0, HEKA, GER). ICa,L was
activated by clamping the cells from a holding potential of -40-0 mV
for 250 ms every 10 s. The current can be virtually inhibited by the
calcium blocker (diltiazem,100mmol/L) and is proven to be ICa,L. Peak
ICa,L was measured with respect to steady-state current and was not
compensated for leak currents.
2.4. Chemical drug
GSRd (awhite powder with purity98%) was obtained from the
National Institute of Control of Pharmaceutical and Biological
Products of China. Other chemical drugs were purchased from
Sigma-Aldrich China Inc.
2.5. Data analysis
Software Origin8.0 (OriginLab Corp., USA) and Excel 2007
(Microsoft, Redmond,WA, USA)were used for data analysis. Data are
presented asmean standard deviation. Student paired or unpaired
t test was applied to determine the difference between the two
groups, and p < 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Effects of GSRd on ICa,L in rat ventricular myocytes
GSRd inhibited the peak amplitude of ICa,L in a concentration-
dependent manner (Fig. 1). The time course of block of ICa,L by GSRd
(10 mmol/L, 30 mmol/L, and 100 mmol/L) is illustrated in Fig. 1A. Therecovery was incomplete during the washout period. In super-
imposed traces, there was a virtual change in peak amplitude and
no change in inactivation course and peak time (Fig. 1B). The dosee
response curve for GSRd-induced inhibition of ICa,L was constructed
from the mean peak ICa,L at each concentration of GSRd (Fig. 1C). On
the basis of cell-by-cell ﬁts, the half-maximal inhibitory concen-
tration (IC50) of GSRdwas 32.47.1 mmol/L with a Hill coefﬁcient of
1.71 (n ¼ 21 cells).
3.2. Effects of GSRd on currentevoltage relationship of ICa,L
Fig. 2 shows the IeV relationship of ICa,L in the absence or
presence of GSRd. Familymembers of ICa,L were elicited from40 to
Fig. 4. Effect of ginsenoside Rd (GSRd) on the recovery from inactivation. Kinetics of
recovery assessed with two 200 ms test pulses separated by various intervals from
2 ms to 1280 ms at a holding potential of 40 mV. The time course of recovery from
inactivation was estimated by plotting the ratio of peak ICa,L of the second pulse to that
of the ﬁrst pulse versus interpulse interval. Mean values were ﬁtted by a single
exponential function. Recovery was only 87.2  2.4% (n ¼ 5), and the time constants
were 90.62  7.05 ms for the control and 135.98  6.39 ms for 30 mmol/L GSRd (n ¼ 5).
J Ginseng Res 2015;39:169e177172between 40 and þ70 mV within 250 ms (Fig. 2A). The effects of
GSRd on the currentevoltage relationship of ICa,L was shown by the
mean peak current density from each depolarizing step pulses. ICa,L
was activated at 30 mV, and the peak amplitude occurred at the
potential of 0 mV. GSRd (10 mmol/L and 30 mmol/L) up-shifted the
IeV curve, and the current density at potential of 0 mV was
decreased from 12.98  1.39 pA/pF to 10.74  1.32
and8.810.66 pA/pF (n¼ 5, p< 0.05) (Fig. 2B). GSRd did not alter
the characteristics of the IeV relationship (the maximal activation
voltage and reversal potential).
3.3. Effects of GSRd on activation and inactivation of ICa,L
Steady-state activation and inactivation curves were obtained
before and after GSRd application (Fig. 3). The activation curves
were derived from the currentevoltage relationship and ﬁtted with
the Boltzmann equation:
G=Gmax ¼ 1=f1þ exp ½ðV  V0:5Þ=kg:washout
control 
washout
control 
GSRd100 
GSRd100 
A 
whole-cell recording perforated patch re
Fig. 5. Different inhibition potency by whole-cell recording and perforated patch recordin
whole-cell recording and perforated patch recording, respectively. (B) Percent inhibition o
recording.GSRd (30 mmol/L) shifted V0.5 from 19.12  0.68
to16.26 0.38mV (n¼ 5, p< 0.05) and shifted k from 4.26 0.78
to 4.61  0.32 (n ¼ 5, p > 0.05). The steady-state inactivation of ICa,L
was obtained using a double-pulse protocol. The inactivation
curves before and after GSRd application were well described by a
Boltzmann equation:
I=Imax ¼ 1=½1þ expðV  V0:5Þ=k:
In this investigation, V0.5 and k were 28.34  0.45 mV and
4.41  0.42 mV in the controls and 28.99  0.28 mV and
4.21  0.28 mV after 30 mmol/L GSRd was applied (n ¼ 5, p＞ 0.05).3.4. Effects of GSRd on recovery from inactivation of ICa,L
The effect of GSRd (30 mmol/L) on recovery from inactivation of
ICa,L was examined using a double-pulse protocol separated by
various intervals (Fig. 4). The ICa,L recovery was not complete
(87.2  2.4%, n ¼ 5). The mean recovery time constant (z) of ICa,L
from inactivation signiﬁcantly increased from 91ms to 136ms after
30 mmol/L GSRd was added (n ¼ 5, p < 0.01).3.5. Different potency by whole-cell and perforated patch recording
In order to examine whether the mechanism of GSRd-induced
inhibition was attributable to intracellular signaling cascades or
banding to the calcium channel directly, we undertook an addi-
tional experiment by using the conventional whole-cell patch
technique. In whole-cell recording, the cutting off of the peak
currents turned weaker as a result of the application of 100 mmol/L
GSRd (Fig. 5) [63.4  9.1% in perforated patch recording (n ¼ 6) vs.
31.4  5.2% in whole-cell recording reduction (n ¼ 5), p < 0.01].3.6. Effects of pertussis toxin on GSRd-induced inhibition
We hypothesized that Gi protein activationmight be responsible
for the GSRd-induced inhibition on ICa,L. Myocytes were pretreated
with pertussis toxin (PTX) for 6 h at 37C to decouple Gi from
associated stimulation. In PTX-treated cells, under the control
condition, ICa,L was similar to that of untreated cells
[10.24  2.13 pA/pf (n ¼ 5) vs. 9.88  1.72 pA/pf (n ¼ 5), p > 0.05].
After the application of 30 mmol/L GSRd, ICa,L did not show any
change when compared with controls (n ¼ 5; Fig. 6A, 6B).cording  
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g. (A) Example of the effect of ginsenoside Rd (GSRd; 100 mmol/L) on basal ICa,L using
f ICa,L induced by GSRd (100 mmol/L) though whole-cell recording or perforated patch
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C
D
Fig. 6. Effect of ginsenoside Rd (GSRd) on ICa,L of myocyte pretreated with pertussis toxin, ISO, and forskolin. The left panels in this and the following ﬁgures represent peak
amplitude of ICa,L in a representative myocyte against the time. The timing of the drug applications is shown on the top. The right panel depicts superimposed current traces
recorded at the timing indicated by lower-case letters in the left panel. (A) Effects of GSRd (30 mmol/L) on ICa,L. (B) Effects of GSRd (30 mmol/L) on ICa,L of myocyte pretreated
with pertussis toxin. (C) Effects of GSRd (30 mmol/L) on ICa,L that had been stimulated by ISO (1mmol/L). (D) Effects of GSRd (30 mmol/L) on ICa,L stimulated by forskolin
(10 mmol/L).
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J Ginseng Res 2015;39:169e1771743.7. Effects of GSRd on ICa prestimulated with two cyclic adenosine
monophosphate elevating agents
It is known that Gi counteracts the Gs-coupled activation of
adenylate cyclase, reducing the production of cyclic adenosine
monophosphate (cAMP) [10e12]. We examined how GSRd affected
the calcium current in the myocytes pretreated with isoproterenol
(ISO), which has the Gs-coupled activation of adenylate cyclase via
the b-adrenergic pathway that leads to promotion of the produc-
tion of cAMP, activation of protein kinase A, and phosphorylation of
many proteins including the L-type Ca2þ channel [13,14]. Super-
fusion of myocytes with ISO (1 mmol/L) induced a signiﬁcant
enhancement effect on ICa,L (196  37% of control, n ¼ 10). GSRd
(30 mmol/L) injection in the presence of ISO caused a substantial
inhibition of ICa,L (Fig. 6A, 6C). Forskolin, a direct activator of ade-
nylate cyclase, was also used to test how GSRd affected ICa,L.
Following superfusion with forskolin (10 mmol/L), ICa,L was
increased to 250  16% of the controls (n ¼ 8), and GSRd (30 mmol/
L) also inhibited the ICa,L of myocytes prestimulated with forskolin
(Fig. 6D). However, in contrast to the substantial inhibition of ICa,L
by GSRd in ISO-pretreated myocytes, GSRd application in the
presence of forskolin had a relatively weaker inhibitory effect on
ICa,L [17.2  3.5% (n ¼ 5) vs. 55  7.8% (n ¼ 5), p < 0.01].3.8. Effect of N-acetyl-L-cysteine and 1H-[1,2,4]oxadiazolo[4,3-a]-
quinoxalin-1- one
Because some ginsenosides such as Re,Rg3 involve the actions
of nitric oxide (NO) [15], we hypothesized a possible involvementFig. 7. Effect of NAC and ODQ on the inhibition of ICa,L by GSRd. (A) Effect of an NO scavenge
guanylate cyclase, ODQ (10 mmol/L), on the inhibition of ICa,L by GSRd (30 mmol/L). GSRd, gin
a]-quinoxalin-1-one.of the NOecyclic guanosine monophosphate (cGMP) signal
pathway in the actions of GSRd. We ﬁrst examined the effects of
N-acetyl-L-cysteine (NAC), an NO scavenger, on the inhibition by
GSRd. Cells were incubated with NAC (10 mmol/L) for 15 min.
There was no change in peak ICa,L in the absence or presence of
NAC. In the presence of NAC, the inhibition depth of GSRd
(30 mmol/L) was decreased when compared with the control cell
treated with the same concentration of GSRd (Fig. 6A, 7A). The
inhibition rate of NAC-incubating myocytes (15.7  3.2%, n ¼ 5)
was signiﬁcantly different from that of control cells (31.4  4%,
n ¼ 6; p < 0.01). An inhibitor of NO-sensitive guanylate cyclase,
1H-[1,2,4]oxadiazolo[4,3-a]-quinoxalin-1-one (ODQ), was also
tested to observe the inhibitory effect of GSRd. In the presence of
ODQ (10 mmol/L), even though the peak ICa,L was slightly lower
(95.7  1.4% relative to the control, n ¼ 5), the inhibition rate of
30 mmol/L GSRd declined from 31.4  4% (n ¼ 6) to 21.4  5.2%
(n ¼ 5) (p < 0.05; Fig. 6A, 7B).3.9. Effect of phorbol-12-myristate-13-acetate and GF109203X
We also investigated if the effect of GSRd on ICa,L was mediated
through protein kinase C (PKC) signals. Phorbol-12-myristate-13-
acetate (PMA), a PKC activator, slightly increased the peak ampli-
tude (w10% that of controls, n ¼ 5). In the presence of 10 mmol/L
PMA, GSRd (30 mmol/L) cut off the peak amplitude. There was no
signiﬁcant difference in GSRd-induced ICa,L inhibition between
non-PMA (31.4  4%, n ¼ 6) and PMA (36.4  5.9%, n ¼ 6) (Fig. 6A,
8A). In the presence of a PKC inhibitor, GF109203X (10 mmol/L), no
change in peak ICa,L was found. The presence of GF109203X did notr, NAC (10 mmol/L), on ICa,L inhibited by GSRd (30 mmol/L). (B) Effects of an inhibitor of
senoside Rd; NAC, N-acetyl-L-cysteine; NO, nitric oxide; ODQ, 1H-[1,2,4]oxadiazolo[4,3-
C. Lu et al / Effect of ginsenoside Rd on L-type Ca2+ channel 175affect GSRd-induced ICa,L inhibition [31.4  4% (n ¼ 6) vs.
34.7  5.8% (n ¼ 5), p > 0.05; Fig. 6A, 8B).
4. Discussion
The present study demonstrates that GSRd causes ICa,L inhibition
in rat ventricular myocytes, which is coupled with PTX-sensitive G
protein (Gi) and partly mediated through an NOecGMP-dependent
mechanism.
4.1. Effects of GSRd on ICa,L
We found for the ﬁrst time that GSRd inhibited ICa,L in rat ven-
tricular myocytes in a concentration- and voltage-dependent
manner. The results suggest that GSRd can prohibit the inﬂux of
excessive Ca2þ through the inhibition of voltage-dependent cal-
cium channel (VDCC) in ventricular myocytes, which may be a new
mechanism for protecting the heart against ischemia reperfusion
injury. However, these results are not in accordance with previous
reports that GSRd had no effect on the VDCC and could inhibit Ca2þ
inﬂux via receptor- and store-operated Ca2þ channels in basilar
arterial vascular smooth muscle cells. In fact, some calcium channel
blockers have different sensitivities to the VDCC in the cardiac or
smooth muscle cells, which have been proven to contribute to
cardiac and arterial smooth muscle Cav1.2 calcium channels iso-
forms diversiﬁed by alternative splicing [16e18]. More studies areA 
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Fig. 8. Effect of PMA and GF109203X on inhibition of ICa,L by GSRd. (A) Effect of a PKC activa
inhibitor, GF109203X (10 mmol/L), on the inhibition of ICa,L by GSRd (30 mmol/L). GSRd, ginsen
acetate.needed to explore whether or which calcium channel isoforms are
related to the different impacts of GSRd.
GSRd was assumed to cause the later activation of calcium
channels, as well as the slow and incomplete recovery from the
inactivation state. These might reﬂect the slow unbinding rate of
the dissociation of the chemical drug, and the fact that about 10% of
the channels would not be dissociated.
4.2. Possible mechanism of GSRd on ICa,L
Almost all calcium antagonists, such as dihydropyridines,
benzothiazepines, and phenylalkylamines, act by directly binding
to the calcium channel protein; however, many extracellular
hormones and drugs can also regulate the calcium channel by
binding to a variety of transmembrane receptors, initiating
multiple signaling cascades [19,20]. When conventional whole-
cell patch recording voltage clamp is used, the intracellular
environment of the test cell would be altered by the dialysis of
the cytoplasmic constituents. This phenomenon results to a
change in the effective potency of some drugs that regulate the
calcium channel via a signal pathway. The different potency in
whole-cell and perforated patch recording led to us focus on the
signal pathway as a modulation mechanism of GSRd on ICa,L. In
some reports, a PTX-sensitive G protein (Gi) was assumed to
participate in N-type and other high-threshold Ca2þ channels
inhibition evoked by some ginsenosides such as Rf, Rb1, Rc, Re,14
4
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tor, PMA (10 mmol/L), on the inhibition of ICa,L by GSRd (30 mmol/L). (B) Effects of a PKC
oside Rd; PKA, protein kinase A; PKC protein kinase C; PMA, phorbol-12-myristate-13-
J Ginseng Res 2015;39:169e177176and Rg1 in rat sensory neurons [21,22], so we hypothesized that
Gi activation might be responsible for the GSRd-induced inhibi-
tion of ICa,L. In the present study, GSRd-induced inhibition of ICa,L
in rat ventricular myocytes was also virtually eliminated by PTX.
Thus, it is reasonable to deduce that the Gi signal pathway is
responsible for the GSRd-induced inhibition of ICa,L. It is known
that Gi counteracts the Gs-coupled activation of adenylate
cyclase, thereby reducing the production of cAMP, so we tested
the effects of GSRd on ICa prestimulated with two cAMP elevating
agents. In the presence of ISO (b1-AR activator), GSRd caused
more signiﬁcant ICa,L inhibition (ISO vs. non-ISO: 55  7.8% vs.
31.4  4%) and showed an antiadrenergic effect. In contrast to the
substantial inhibition in the ISO-pretreated myocytes, 10 mmol/L
forskolin caused a relatively weaker ICa,L inhibition (17.2  3.5%
vs. 55.0  7.8%). Because forskolin is thought to be a direct
activator of adenylate cyclase (AC), it is proposed that Gi-induced
inhibition of AC is only relative to the Gs-mediated AC stimula-
tion, and direct activation of AC cannot be fully suppressed by Gi,
which may explain the different effects induced by ISO and for-
skolin. Therefore, the difference inhibition potency between the
two elevating cAMP agents suggests GSRd-induced inhibition
links to the Gi signal pathway.
The downstream signaling pathways from Gi responsible for L-
type calcium channel in cardiac myocytes are not well known.
Some evidence shows NO-dependent mechanisms involved in the
regulation of L-type calcium channel coupled with Gi: (1) phos-
phatidylinositol 3-kinase (PI3K), a downstream signaling pathway
of Gi, acted on NO synthase-3 [23e26]; (2) NO was shown to
inhibit ICa,L [27]; and (3) cGMP, a downstream signal molecule of
NO, was involved in the reduced basal and cAMP-elevated L-type
calcium current [28,29]. Our data showed that NAC, an NO scav-
enger, and ODQ, an inhibitor of NO-sensitive guanylate cyclase,
partly alleviated GSRd-induced ICa,L inhibition, suggesting that
GSRd inhibits ICa,L via an NO action in which the cGMP-dependent
pathway is responsible. Thus, GSRd-induced inhibition linked to
the NOecGMP signal pathway may be a Gi protein-dependent
mechanism.
Finally, we also tested if the effects of GSRd on ICa,L are mediated
through the PKC signal pathway. Although some hormones such as
angiotensin II and acetylcholine enhance ICa,L via PKC involvement,
the effect of PKC on L-type channels is contradictorydenhance-
ment, inhibition, and biphasic effects have been described about
PKC activators on ICa,L [30e32]. Discrepant effects on ICa,L can arise
from diverse CaV1.2 splice variants and from the intricacies of Gq
signaling, including differential Gbg subunits following receptor
activation [33]. Our data suggest that GSRd inhibits ICa,L through a
pathway distinct from that of PKC, because a PKC activator and a
PKC inhibitor had no effect on the inhibition of GSRd.
Although the present study demonstrates that GSRd causes
ICa,L inhibition through the Gi protein and the NOecGMP signal
pathway, we did not address the issue onwhether the effect of the
NOecGMP signal pathway is via a pathway dependent on Gi
protein action induced by GSRd. Because GSRd had been
demonstrated to be antiapoptotic by activating PI3K/Akt and Akt/
GSK-3 signaling in rat intestinal epithelial cells and neonatal rat
cardiomyocytes [4,34], we hypothesized that NO production
induced by GSRd may stem from the action of NO synthase (NOS)
carried out by PI3K, a downstream signaling pathway of the Gi
protein. The remaining issues to be addressed include ﬁnding out
whether or not NOS is activated by GSRd and which pathway links
GSRd to NOS activation.
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